Skip to content

Modified peroral endoscopic myotomy (Liu-POEM) versus conventional POEM for the treatment of achalasia: A prospective multicenter randomized controlled clinical trial

Modified peroral endoscopic myotomy (Liu-POEM) versus conventional POEM for the treatment of achalasia: A prospective multicenter randomized controlled clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-15005974
Enrollment
Unknown
Registered
2015-01-06
Start date
2015-03-01
Completion date
Unknown
Last updated
2017-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Achalasia

Interventions

A:Liu-POEM
B:conventional POEM

Sponsors

the second affiliated hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients aged between 18 and 80 years, body mass index less than 40kg/?; The diagnosis of achalasia was based on clinical symptoms(Eckardt score>3): dysphagia,regurgitation, chest pain, weight loss; Barium esophagogram demonstrating consecutive dilatation of the esophageal body, typical 'bird's peak' appearance of the LES with decrease in emptying times; Patients with no severe achalasia (X-ray showed expansion and s-shaped tortuosity of the lower esophagus).

Exclusion criteria

Exclusion criteria: (1) Patients refused to sign the informed consent; (2) inability to tolerate general anesthesia; (3) Pregnant women or lactating women; (4) Long-time use of hormone therapy or anticoagulant therapy; (5) Patients with a life expectancy less than 6 month; (6) severe pulmonary disease and renal insufficiency (Blood creatinine >200 umol/L); (7)severe achalasia (X-ray showed expansion and s-shaped tortuosity of the lower esophagus); (8) cirrhosis with portal hypertension; (9) patients have concomitant esophageal or upper gastric tumors; (10) Patient who has took part in other studies that can affect results of the present study.

Design outcomes

Primary

MeasureTime frame
operation time;Symptom remission rate (Eckardt score);complications and recurrence in short-term follow-up (6months);

Secondary

MeasureTime frame
frequency of regular hemostasis;submucosal tissuhealing time;eduration of postoperative pain;Esophageal X-ray angiography (shape and width of esophagus);Pain medication requirements;tissue injury (assessed by MRI);length of hospital stay;hospitalization expenses;

Countries

China

Contacts

Public ContactLiu Binrong
liubingrong@medmail.com.cn+86 13313695959

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026